中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
9期
828-829,832
,共3页
魏豫东%杨丽%张双%郭京川%李海燕%孙玉梅
魏豫東%楊麗%張雙%郭京川%李海燕%孫玉梅
위예동%양려%장쌍%곽경천%리해연%손옥매
Ⅰ期临床试验%问卷调查%受试者保护%补偿
Ⅰ期臨床試驗%問捲調查%受試者保護%補償
Ⅰ기림상시험%문권조사%수시자보호%보상
phase I clinical study%questionnary investigation%volun-teers protection%paid
目的:研究参加I期临床试验的健康志愿者对临床研究的认知程度及其影响因素。方法用公众对临床研究的认识和对临床研究知识的知晓程度( PARTAKE)问卷对北京大学第三医院药物临床试验机构100例曾参与I期临床试验的健康志愿者进行问卷调查。结果100例志愿者中,96.0%认为临床研究对社会有益;91.0%认为人体试验对于开发新的治疗方法是必要的;90.0%以上对于临床研究中自愿参与、信息保密等受试者保护问题持认可态度;18.0%认为在临床试验中发生的伤害事件,肯定是由于试验治疗造成的;81.0%认为在临床研究中,如果参与者出现任何不良结果,都会得到充分的补偿。结论在Ⅰ期临床试验中,健康志愿者对临床研究的认知总体较好;对受试者保护有一定理解,但对知情同意过程中伤害补偿问题理解不充分。
目的:研究參加I期臨床試驗的健康誌願者對臨床研究的認知程度及其影響因素。方法用公衆對臨床研究的認識和對臨床研究知識的知曉程度( PARTAKE)問捲對北京大學第三醫院藥物臨床試驗機構100例曾參與I期臨床試驗的健康誌願者進行問捲調查。結果100例誌願者中,96.0%認為臨床研究對社會有益;91.0%認為人體試驗對于開髮新的治療方法是必要的;90.0%以上對于臨床研究中自願參與、信息保密等受試者保護問題持認可態度;18.0%認為在臨床試驗中髮生的傷害事件,肯定是由于試驗治療造成的;81.0%認為在臨床研究中,如果參與者齣現任何不良結果,都會得到充分的補償。結論在Ⅰ期臨床試驗中,健康誌願者對臨床研究的認知總體較好;對受試者保護有一定理解,但對知情同意過程中傷害補償問題理解不充分。
목적:연구삼가I기림상시험적건강지원자대림상연구적인지정도급기영향인소。방법용공음대림상연구적인식화대림상연구지식적지효정도( PARTAKE)문권대북경대학제삼의원약물림상시험궤구100례증삼여I기림상시험적건강지원자진행문권조사。결과100례지원자중,96.0%인위림상연구대사회유익;91.0%인위인체시험대우개발신적치료방법시필요적;90.0%이상대우림상연구중자원삼여、신식보밀등수시자보호문제지인가태도;18.0%인위재림상시험중발생적상해사건,긍정시유우시험치료조성적;81.0%인위재림상연구중,여과삼여자출현임하불량결과,도회득도충분적보상。결론재Ⅰ기림상시험중,건강지원자대림상연구적인지총체교호;대수시자보호유일정리해,단대지정동의과정중상해보상문제리해불충분。
Objective To study knowledge of healthy volunteers in-volved in Phase ⅠClinical Studies to clinical researches and related fac-tors.Methods The public awareness of research for therapeutic ad-vancements through knowledge and empowerment (PARTAKE) question-naires, designed by Duke University , were administered to 100 partici-pants in phaseⅠclinical study in Peking university third hospital.Re-sults The following perceptions were reported: research benefited our society (96.0%) , human experiment was necessary for developing new therapeutic method (91.0%), confidentiality and voluntary participating were adequately approved ( 90.0%) , all the undesirable effects were caused by the research ( 18.0%) , and volunteers would be paid for any undesirable adverse reactions completely ( 81.0%).Conclusion Re-sults suggest that the healthy volunteers have a good command of clinical research generally.They are aware of protections to participants , but they do not have a full understanding of compensation for damages .